Coronavirus (COVID-19) - Latest Information for Patients and Visitors

(La más reciente información para pacientes y visitantes)

 

Read Now (Lea ahora)
800-TEMPLE-MED Schedule Appointment
SEARCH TEMPLE HEALTH

The Academic Times Highlights Research from Dr. Walter Koch, Former Graduate Student Dr. Ryan Coleman and Lewis Katz School of Medicine Colleagues on GRK5

View All News

The Academic Times interviewed Walter J. Koch, PhD, W.W. Smith Endowed Chair in Cardiovascular Medicine, Professor and Chair of the Department of Pharmacology and Director of the Center for Translational Medicine at the Lewis Katz School of Medicine at Temple University, about recent research published online in the journal Science Signaling that showed for the first time in animals that keeping a signaling protein known as G protein-coupled kinase 5 (GRK5) out of the heart cell nucleus can block maladaptive growth of the heart. The findings open avenues for the development of GRK5-based therapies to prevent heart failure. Dr. Koch is the senior investigator on the study, and Dr. Ryan C. Coleman, a former graduate student in the Koch laboratory, is first author on the report.